Filing Details
- Accession Number:
- 0001181431-13-037361
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-01 12:31:53
- Reporting Period:
- 2013-06-28
- Filing Date:
- 2013-07-01
- Accepted Time:
- 2013-07-01 12:31:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 908259 | Oxigene Inc | OXGN | Biological Products, (No Disgnostic Substances) (2836) | 133679168 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1282829 | Peter Langecker | C/O Oxigene, Inc. 701 Gateway Blvd. South San Francisco CA 94080 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2013-06-28 | 3,000 | $2.75 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
